Phase 1 × Completed × Uterine Cervical Neoplasms × Clear all MK-4700-001
Phase 1 Completed
5 enrolled
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Phase 1 Completed
15 enrolled 16 charts
HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer
Phase 1 Completed
9 enrolled
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Phase 1 Completed
69 enrolled
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Phase 1 Completed
40 enrolled 17 charts
ARC-12
Phase 1 Completed
94 enrolled
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
Phase 1 Completed
17 enrolled
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
Phase 1 Completed
12 enrolled 18 charts
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Phase 1 Completed
285 enrolled
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
Phase 1 Completed
26 enrolled
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1 Completed
54 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
Phase 1 Completed
269 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Phase 1 Completed
110 enrolled
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Phase 1 Completed
60 enrolled
5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa
Phase 1 Completed
12 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Phase 1 Completed
21 enrolled
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Phase 1 Completed
12 enrolled 18 charts
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Phase 1 Completed
150 enrolled 12 charts
Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
Phase 1 Completed
25 enrolled 14 charts
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
Phase 1 Completed
277 enrolled
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
Feasibility of ReSpaceâ„¢ Hydrogel to Establish a Stable Cervical-rectal Space
Phase 1 Completed
8 enrolled
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
Phase 1 Completed
20 enrolled
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Phase 1 Completed
75 enrolled
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
Phase 1 Completed
90 enrolled
DUET-4
Phase 1 Completed
78 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Phase 1 Completed
160 enrolled
DUET-2
Phase 1 Completed
150 enrolled
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
Phase 1 Completed
104 enrolled 23 charts
A Phase I Clinical Trial of Bevacizumab Injection
Phase 1 Completed
98 enrolled
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Phase 1 Completed
6 enrolled
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Phase 1 Completed
174 enrolled 68 charts
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor
Phase 1 Completed
67 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
Phase 1 Completed
35 enrolled
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Phase 1 Completed
40 enrolled
PROLOG
Phase 1 Completed
12 enrolled
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
Phase 1 Completed
72 enrolled
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Phase 1 Completed
11 enrolled
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Phase 1 Completed
24 enrolled
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Phase 1 Completed
8 enrolled